Dr. Robert H. Li, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 413
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
PA license MD071283L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Penn Presbyterian Medical Center Philadelphia, PA
- Pennsylvania Hospital Philadelphia, PA
- Shore Medical Center Somers Point, NJ
Medical groups
- Clinical Health Care Associates of New Jersey PC (797 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 413
- Services billed
- 1,354
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 169 | 166 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | 122 |
| Replacement of aortic valve through the skin and femoral artery | 122 | 122 |
| New patient office or other outpatient visit, 60-74 minutes | 96 | 96 |
| Injection for imaging of aorta above heart valve with review by radiologist | 93 | 93 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 90 | 55 |
| Established patient office or other outpatient visit, 40-54 minutes | 81 | 62 |
| Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta | 76 | 76 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 60 | 60 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 57 | 31 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Philadelphia, PA | 84 |
| Metoprolol Succinate Other prescribers in Philadelphia, PA | 49 |
| Rosuvastatin Calcium Other prescribers in Philadelphia, PA | 33 |
| Amlodipine Besylate Other prescribers in Philadelphia, PA | 32 |
| Eliquis (apixaban) Other prescribers in Philadelphia, PA | 28 |
| Hydrochlorothiazide Other prescribers in Philadelphia, PA | 20 |
| Lisinopril Other prescribers in Philadelphia, PA | 19 |
| Entresto (sacubitril/valsartan) Other prescribers in Philadelphia, PA | 17 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Philadelphia, PA | 15 |
| Pravastatin Sodium Other prescribers in Philadelphia, PA | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 29 payments worth $1,275 in total to this clinician.
| Abbott Laboratories | $458 |
|---|---|
| Medtronic, Inc. | $358 |
| Shockwave Medical, Inc | $175 |
| W. L. Gore & Associates, Inc. | $150 |
| Edwards Lifesciences Corporation | $122 |
| Procyrion, Inc. | $12.18 |
| Food and Beverage | $1,275 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $23,667 in research payments for these studies, mostly to the institutions running them.
- SMART Trial
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.